[1]
T. TCHUMBURIDZE, N. NEMSITSVERIDZE, T. CHIKVILADZE, N. KALATOZISHVILI, and I. TOMADZE, “RISKS OF POLYPHARMACY IN THE TREATMENT OF HYPERTENSION”, jecmg, no. 4, pp. 48–52, Nov. 2023.